IRIS
BATTAGLIA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.352
EU - Europa 10.503
AS - Asia 9.005
SA - Sud America 2.539
Continente sconosciuto - Info sul continente non disponibili 709
AF - Africa 326
OC - Oceania 16
AN - Antartide 2
Totale 48.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.702
IT - Italia 4.795
SG - Singapore 3.772
CN - Cina 2.032
BR - Brasile 2.029
HK - Hong Kong 1.167
SE - Svezia 970
DE - Germania 896
RU - Federazione Russa 814
UA - Ucraina 735
FR - Francia 661
FI - Finlandia 598
VN - Vietnam 549
GB - Regno Unito 458
CA - Canada 302
IN - India 282
BD - Bangladesh 266
AR - Argentina 184
IQ - Iraq 131
ID - Indonesia 101
MX - Messico 96
BE - Belgio 95
TR - Turchia 94
CO - Colombia 89
ZA - Sudafrica 89
IE - Irlanda 78
NL - Olanda 74
SA - Arabia Saudita 73
PK - Pakistan 72
EC - Ecuador 69
VE - Venezuela 68
JP - Giappone 63
LT - Lituania 57
ES - Italia 54
PH - Filippine 54
UZ - Uzbekistan 53
PL - Polonia 52
CI - Costa d'Avorio 42
CR - Costa Rica 41
MA - Marocco 38
HN - Honduras 34
CH - Svizzera 32
IL - Israele 32
KE - Kenya 28
MY - Malesia 28
CL - Cile 25
JM - Giamaica 25
GT - Guatemala 24
IR - Iran 24
NI - Nicaragua 24
AZ - Azerbaigian 23
JO - Giordania 23
TT - Trinidad e Tobago 23
TN - Tunisia 22
PE - Perù 21
SC - Seychelles 21
PY - Paraguay 20
AE - Emirati Arabi Uniti 19
SV - El Salvador 19
KR - Corea 18
AT - Austria 17
PR - Porto Rico 17
UY - Uruguay 16
EG - Egitto 15
CW - ???statistics.table.value.countryCode.CW??? 14
ET - Etiopia 14
TH - Thailandia 14
AU - Australia 13
KZ - Kazakistan 13
LB - Libano 13
OM - Oman 13
RO - Romania 13
BO - Bolivia 12
GP - Guadalupe 12
PS - Palestinian Territory 12
CZ - Repubblica Ceca 11
NP - Nepal 11
AL - Albania 10
PT - Portogallo 10
RS - Serbia 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
BB - Barbados 8
EU - Europa 8
BH - Bahrain 7
PA - Panama 7
EE - Estonia 6
HR - Croazia 6
HU - Ungheria 6
BY - Bielorussia 5
CG - Congo 5
GE - Georgia 5
GR - Grecia 5
KG - Kirghizistan 5
SN - Senegal 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BF - Burkina Faso 4
DK - Danimarca 4
Totale 47.662
Salva come PNG Salva come JPEG
Città #
Ashburn 2.791
Singapore 2.033
Fairfield 2.021
San Jose 1.738
Chandler 1.714
Jacksonville 1.625
Woodbridge 1.433
Hong Kong 1.159
Milan 1.038
Houston 894
Seattle 870
Cambridge 767
Wilmington 709
Nyköping 659
Ann Arbor 636
Council Bluffs 597
Beijing 546
Rome 471
New York 441
Roxbury 415
Lawrence 414
Nanjing 391
Lauterbourg 363
Los Angeles 313
Dallas 298
Des Moines 278
Bari 272
São Paulo 225
Santa Clara 221
Boardman 191
Helsinki 185
Princeton 181
Ho Chi Minh City 174
Columbus 158
Munich 154
Buffalo 127
Brooklyn 123
Turin 115
Shenyang 107
Hanoi 102
London 102
Nanchang 102
San Diego 99
Inglewood 97
Hebei 95
Naples 92
Brussels 89
Chicago 89
Toronto 85
Figino 76
Dearborn 75
Dong Ket 73
Dublin 73
Atlanta 72
Jiaxing 72
Montreal 64
Rio de Janeiro 64
Florence 63
Frankfurt am Main 60
Tianjin 60
Changsha 59
Paris 58
Phoenix 58
Redwood City 56
Bologna 55
Baghdad 53
Belo Horizonte 53
Orem 53
Pune 51
Tokyo 50
Tashkent 48
The Dalles 48
Palermo 46
San Francisco 46
Brasília 44
Jakarta 44
Abidjan 42
Boston 42
Washington 41
Johannesburg 40
Moscow 40
Turku 40
Vilnius 39
Warsaw 37
Curitiba 36
Campinas 35
Nuremberg 33
San José 32
Stockholm 32
Chennai 30
Guangzhou 29
Denver 28
North Bergen 28
Riyadh 28
Buenos Aires 27
Falls Church 27
Mexico City 27
Augusta 26
Bogotá 26
Caracas 26
Totale 30.164
Salva come PNG Salva come JPEG
Nome #
L’INFILTRAZIONE PERINEURALE E LA POSITIVITA’ DEI MARGINI CHIRURGICI NELLA PROGNOSI DEI PAZIENTI CON CARCINOMA PROSTATICO SOTTOPOSTI A PROSTATECTOMIA RADICALE. 1.672
ACCESSO LOMBOTOMICO VS ACCESSO TRANSPERITONEALE NELLA CHIRURGIA DEL CARCINOMA RENALE. RISULTATI PRELIMINARI DI UNO STUDIO RANDOMIZZATO. 716
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 478
LE ANASTOMOSI URETERO-INTESTINALI: CONDOTTO ILEALE CON URETERO - ILEOANASTOMOSI SECONDO WALLACE. 289
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 277
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 240
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 240
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 235
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 229
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. 228
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 222
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 220
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 219
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 219
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 217
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 215
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 211
Isolation and characterization of cancer stem cells in renal cell carcinoma. 209
LA FISTOLA CAVERNO-SPONGIOSA SECONDO WINTER NEL TRATTAMENTO DEL PRIAPISMO IDIOPATICO. 208
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 207
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 203
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 193
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 189
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 184
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 184
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 184
Bilateral tumors of the testis in 21-alpha hydroxylase deficiency without adrenal hyperplasia 182
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 180
ANGIOMIOLIPOMA CALCIFICO DEL RENE. 178
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 177
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 177
Allograft nephrectomy: what is the best surgical technique? 177
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 177
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 176
Complement-dependent NADPH oxidase enzyme activation in renal ischemia/reperfusion injury. 174
Interleukin-27 is a potential marker for the onset of post-transplant malignancies 174
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 173
BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy 172
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine 171
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 170
Penile prosthesis implant: when, what and how 170
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 169
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 167
Predictive value of resistive index in graft survival after kidney transplant. 166
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study 165
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 164
Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer. Anticancer Res. 2009 Oct;29(10):4201-4. PubMed PMID: 19846973 162
Allograft nephrectomy: Intracapsular vs extracapsular tecnique 162
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 162
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 162
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients 161
UROCITOLOGIA E COLPOCITOLOGIA IN CLIMATERIO E NELLA SENILITA' 158
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 158
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function 157
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 157
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial 156
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 154
Lymph node staging in early prostatic carcinoma with radioguided sentinel node biopsy 154
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 153
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 151
Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma. 151
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 151
Repair of vaginal prolapse following penoscrotal flap vaginoplasty in a male-to-female transsexual 150
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 150
Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma 150
"Deviceless" hand-assisted laparoscopic donor nephrectomy 149
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma 149
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 149
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 148
Interferon-alpha (IFN-alpha) –conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients 148
Lethal somatostatin analog-induced acute necrotizing pancreatitis in a patient with hormone-refractory prostate cancer 148
Emerging urinary markers of renal injury in obstructive nephropathy. 148
Single-step surgical tretment of adrenal pheochromocytoma and medullary thyroid carcinoma in Sipple's Syndrome 148
Approccio laparoscopico alla patologia renale 147
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 147
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 147
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 146
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 146
Complement-Mediated Acute Induction of Endothelial-to-Mesenchymal Transition in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 144
Spontaneous rupture of an ileal neobladder 6 years after construction 143
ATTEMPT TO CORRECT IMMUNE DEFICITS IN PATIENTS WITH CHRONIC URINARY-TRACT INFECTION BY ADMINISTRATION OF A THYMIC EXTRACT 143
Penile prosthesis: what should we do about complications? 142
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer 141
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 141
Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction 141
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients 140
Advanced age is not an exclusion criterion for kidney transplantation. 140
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review 140
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 139
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin 139
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 139
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma 139
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 139
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 139
VHL gene alterations in Italian patients with isolated renal cell carcinomas 138
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 138
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 135
The emerging role of obesity, diet and lipid metabolism in prostate cancer 134
Prospective randomized trial comparing high lumbotomic with laparotomic access in renal cell carcinoma surgery 134
GOSERELIN ACETATE WITH OR WITHOUT FLUTAMIDE IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PROSTATE-CANCER 133
Totale 19.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.133 0 0 0 0 159 180 124 169 168 211 464 658
2022/20234.659 708 416 246 459 536 618 94 505 769 55 138 115
2023/20241.708 200 317 110 112 124 448 57 98 23 51 33 135
2024/20256.546 130 136 609 281 160 561 485 578 271 319 960 2.056
2025/202612.871 2.021 488 719 1.287 1.388 712 1.464 368 1.104 1.176 492 1.652
2026/20274.992 646 784 1.357 2.020 185 0 0 0 0 0 0 0
Totale 48.452